NASDAQ:BDTX Black Diamond Therapeutics (BDTX) News Today $3.17 -0.24 (-7.04%) (As of 09/25/2023 ET) Add Compare Share Share Today's Range$3.17▼$3.4050-Day Range$3.08▼$4.8652-Week Range$1.18▼$6.85Volume674,688 shsAverage Volume521,624 shsMarket Capitalization$163.51 millionP/E RatioN/ADividend YieldN/APrice Target$10.50 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCo-founder of cancer biotech Black Diamond replaced as CEOfinance.yahoo.com - September 18 at 1:35 PMBlack Diamond Therapeutics Chairman to Succeed Departing CEOmarketwatch.com - September 18 at 7:46 AMBlack Diamond Therapeutics Announces CEO Transitionfinance.yahoo.com - September 18 at 7:46 AMWedbush Reiterates Black Diamond Therapeutics (BDTX) Outperform Recommendationmsn.com - September 12 at 4:26 PMPiper Sandler Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)markets.businessinsider.com - August 14 at 10:38 AMBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - August 11 at 6:18 PMBlack Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 11 at 6:18 PMBDTX - Black Diamond Therapeutics, Inc.finance.yahoo.com - August 1 at 3:30 PMShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Declines By 38.4%marketbeat.com - July 28 at 8:58 AMBlack Diamond Therapeutics (NASDAQ:BDTX) Receives New Coverage from Analysts at Piper Sandlermarketbeat.com - July 14 at 8:21 AMStifel Upgrades Black Diamond Therapeutics (BDTX)msn.com - July 1 at 1:04 PMGenuine Monotherapy Approach In EGFRm NSCLC: Analyst Upgrades Switches To Buy On Black Diamond Therapeuticsmarkets.businessinsider.com - June 30 at 3:18 PMBlack Diamond Soars on $75M Public Offeringmsn.com - June 30 at 10:17 AMBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Forecasted to Post FY2026 Earnings of ($0.64) Per Sharemarketbeat.com - June 30 at 8:17 AMBlack Diamond Therapeutics Announces Pricing of Public Offering of Common Stockfinance.yahoo.com - June 29 at 11:01 PMWhy Shares of Black Diamond Therapeutics Skyrocketed This Weekfinance.yahoo.com - June 29 at 6:01 PMHC Wainwright & Co. Upgrades Black Diamond Therapeutics (BDTX)msn.com - June 29 at 1:06 AMBlack Diamond Therapeutics Shares Slide After Proposed Public Offeringmarketwatch.com - June 28 at 8:06 PMBlack Diamond Therapeutics proposes $75M stock offeringmsn.com - June 28 at 8:06 PMInstitutions profited after Black Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) market cap rose US$152m last week but private equity firms profited the mostfinance.yahoo.com - June 28 at 10:05 AMWedbush Upgrades Black Diamond Therapeutics (BDTX)msn.com - June 27 at 6:09 PMStifel Reiterates Black Diamond Therapeutics (BDTX) Hold Recommendationmsn.com - June 27 at 6:09 PMBlack Diamond Therapeutics stock rockets after positive trial data shows anti-tumor activityproactiveinvestors.com - June 27 at 1:09 PMBlack Diamond Therapeutics Stock is Shooting Higher Today: Here's Whymsn.com - June 27 at 1:09 PMBlack Diamond Therapeutics Shares Double After Positive Trial Data for BDTX-1535marketwatch.com - June 27 at 1:09 PMBlack Diamond Therapeutics jumps 79% after data for lung cancer therapymsn.com - June 27 at 1:09 PMBlack Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Familiesfinance.yahoo.com - June 27 at 8:08 AMBlack Diamond Therapeutics Announces Promotion of Melanie Morrison to Chief Development Officerfinance.yahoo.com - June 13 at 9:27 AMBlack Diamond Therapeutics Insider Ups Holding By 82% During Yearfinance.yahoo.com - May 25 at 2:58 PMBlack Diamond Therapeutics Insider Ups Holding By 82% During Year \finance.yahoo.com - May 18 at 4:13 PMWedbush Reiterates Black Diamond Therapeutics (BDTX) Neutral Recommendationmsn.com - May 11 at 10:50 AMBerenberg Bank Remains a Buy on Black Diamond Therapeutics (BDTX)markets.businessinsider.com - May 9 at 11:49 PMBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - May 9 at 8:48 AMBlack Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 9 at 8:48 AMBlack Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Daysfinance.yahoo.com - April 18 at 12:59 PMBlack Diamond Therapeutics Presents Trial in Progress Postertmcnet.com - April 17 at 9:54 PMBlack Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data on BDTX-1535 and BDTX-4933 at the 2023 American Association of Cancer Research Annual Meetingfinance.yahoo.com - April 17 at 4:54 PMAnalysts Offer Insights on Healthcare Companies: DarioHealth (DRIO), Fulcrum Therapeutics (FULC) and Black Diamond Therapeutics (BDTX)markets.businessinsider.com - March 13 at 11:03 PMBlack Diamond Therapeutics shares are trading higher after the company reported better-than-expected Q4 EPS results.benzinga.com - March 9 at 5:34 PMBlack Diamond Therapeutics GAAP EPS of -$0.59 beats by $0.04msn.com - March 9 at 5:34 PMBlack Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 9 at 9:34 AMBlack Diamond Therapeutics to Present at the Cowen 43rd Annual Health Care Conferencefinance.yahoo.com - February 27 at 1:51 PMBlack Diamond Therapeutics Inc Ordinary Sharesmorningstar.com - February 10 at 5:42 PMprivate equity firms who own 40% along with institutions invested in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) saw increase in their holdings value last weekfinance.yahoo.com - January 19 at 10:06 AMBlack Diamond Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conferencefinance.yahoo.com - January 5 at 8:21 AMBlack Diamond Therapeutics Announces Changes to Board of Directorsfinance.yahoo.com - December 19 at 9:33 AMBlack Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Companyfinance.yahoo.com - December 12 at 9:03 AMDown 32.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)finance.yahoo.com - December 9 at 4:46 PMBlack Diamond Therapeutics, Inc.'s (NASDAQ:BDTX) recent US$17m market cap decline means a loss of US$21k for insiders who bought this yearfinance.yahoo.com - December 9 at 11:46 AMBlack Diamond Therapeutics: Selling For Large Discount To Cashseekingalpha.com - December 6 at 6:07 PM Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address BDTX Media Mentions By Week BDTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDTX News Sentiment▼-1.000.50▲Average Medical News Sentiment BDTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDTX Articles This Week▼11▲BDTX Articles Average Week Get Black Diamond Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IKNA News Today TNYA News Today XFOR News Today PHXM News Today FUSN News Today GNFT News Today FENC News Today PSTX News Today IVVD News Today ADVM News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:BDTX) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.